NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/31/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/31/24 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 05/14/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
32 |
| 05/13/24 | 8-K | Current report filing |
|
|
6 |
| 05/01/24 | 8-K | Current report filing |
|
|
4 |
| 04/29/24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 04/29/24 | DEF 14A | Definitive proxy statements |
|
43 | |
| 03/29/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
198 |
| 03/27/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/25/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |